Search

everythinglearnresearchcommunity

for

Search:↓

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Finasteride can treat prostatic haematuria, but its use is controversial.

Wheat straw is valuable for its health benefits and various industrial uses.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Female hair loss linked to metabolic syndrome, not in males.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.